Gibson Dunn Advising Serapha Bio on Merger With Boundless Bio and $230 Million Private Financing

Firm News  |  June 25, 2026

---

Gibson Dunn is advising Serapha Bio, Inc. on its merger with Boundless Bio, Inc. and $230 million private financing.

The Gibson Dunn corporate team is led by partners Ryan Murr and Branden Berns and includes associates Matt Finan and Advait Ramanan. Partner Rachel Kleinberg and associate Alex Jinqing Fang are advising on tax aspects. Partner Sean Feller is advising on benefits. Partner Bradley Smith is advising on antitrust aspects. Partner Aaron Briggs is advising on regulatory aspects.